Nyxoah (NASDAQ:NYXH) Trading Up 0.6% – Should You Buy?

Nyxoah S.A. (NASDAQ:NYXH)’s share price rose 0.6% during trading on Thursday . The company traded as high as $10.71 and last traded at $10.57. Approximately 35,985 shares changed hands during trading, a decline of 25% from the average daily volume of 48,234 shares. The stock had previously closed at $10.51.

Analyst Upgrades and Downgrades

NYXH has been the subject of a number of recent analyst reports. HC Wainwright restated a “buy” rating and set a $17.00 target price on shares of Nyxoah in a report on Friday, December 13th. Cantor Fitzgerald restated an “overweight” rating and set a $16.00 target price on shares of Nyxoah in a report on Tuesday, November 5th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Nyxoah currently has a consensus rating of “Buy” and a consensus target price of $17.00.

Nyxoah Stock Performance

The company has a market cap of $358.65 million, a P/E ratio of -5.63 and a beta of 1.41. The business has a fifty day moving average of $9.46 and a 200 day moving average of $8.91. The company has a quick ratio of 4.95, a current ratio of 5.28 and a debt-to-equity ratio of 0.21.

Institutional Investors Weigh In On Nyxoah

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Walleye Capital LLC grew its stake in Nyxoah by 23.9% in the fourth quarter. Walleye Capital LLC now owns 14,831 shares of the company’s stock worth $119,000 after purchasing an additional 2,862 shares during the period. Renaissance Technologies LLC purchased a new stake in Nyxoah in the fourth quarter worth $187,000. Geode Capital Management LLC grew its stake in Nyxoah by 19.4% in the fourth quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock worth $137,000 after purchasing an additional 2,774 shares during the period. LPL Financial LLC purchased a new stake in Nyxoah in the fourth quarter worth $102,000. Finally, Kovack Advisors Inc. grew its stake in Nyxoah by 100.0% in the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock worth $160,000 after purchasing an additional 10,000 shares during the period.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.